| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-06 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.21 | 9e-05 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.18 | 0.0002 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.17 | 0.0004 |